Your browser doesn't support javascript.
loading
Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.
Watson, Dionysios C; Moysi, Eirini; Valentin, Antonio; Bergamaschi, Cristina; Devasundaram, Santhi; Fortis, Sotirios P; Bear, Jenifer; Chertova, Elena; Bess, Julian; Sowder, Ray; Venzon, David J; Deleage, Claire; Estes, Jacob D; Lifson, Jeffrey D; Petrovas, Constantinos; Felber, Barbara K; Pavlakis, George N.
Afiliação
  • Watson DC; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Moysi E; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Valentin A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
  • Bergamaschi C; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Devasundaram S; Human Retrovirus Pathogenesis Section; Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Fortis SP; Human Retrovirus Pathogenesis Section; Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Bear J; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Chertova E; Human Retrovirus Pathogenesis Section; Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Bess J; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Sowder R; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Venzon DJ; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Deleage C; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America.
  • Estes JD; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Lifson JD; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Petrovas C; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Felber BK; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
  • Pavlakis GN; Human Retrovirus Pathogenesis Section; Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
PLoS Pathog ; 14(2): e1006902, 2018 02.
Article em En | MEDLINE | ID: mdl-29474450

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Viral / Linfócitos T Citotóxicos / Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Interleucina-15 / Linfonodos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Viral / Linfócitos T Citotóxicos / Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Interleucina-15 / Linfonodos Idioma: En Ano de publicação: 2018 Tipo de documento: Article